drugset
drugset / Trial / NCT02462070

Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

NCT02462070 ↗

Phase 3 Completed 203 enrolled Bausch Health Americas, Inc. Dow Pharmaceutical Sciences · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of the study is to evaluate the safety and efficacy of a topical lotion.

Timeline

Start
2015-08-11
Primary completion
2016-11-08
Completion
2016-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject IDP-118 Unknown — Topical

Indications

psoriasis